Neuroendocrine and gastrointestinal stromal tumors are the fastest increasing upper GI cancers among young women. Incidence rates of upper gastrointestinal (UGI) cancer have increased faster in young ...

LCCRT results in higher 2-year organ preservation and lower 2-year local regrowth compared with short-course radiotherapy. HealthDay News — For patients with locally advanced rectal cancer pursuing ...

Findings showed 20% of patients treated with dupilumab experienced sustained disease remission at week 36 compared with 4% of those who received placebo. Treatment with dupilumab led to significant ...

Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released.

The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.

Predictors of inadequate bowel preparation (IBP) in colonoscopy include use of Medicaid insurance, low education levels, current tobacco smoking, and Black race, among other factors, according to a ...

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).